Results 191 to 200 of about 1,047,737 (355)
Establishment of Pharmaceutical Care Plan for Liver Cancer Patients and its Clinical Evaluation
Tsuyoshi Maeda+4 more
openalex +2 more sources
After you: conversations between patients and healthcare professionals in planning for end of life care [PDF]
Kathryn Almack+4 more
openalex +1 more source
Impact of the Northwest London Integrated Care Pilot on diabetes control
Michael Soljak+4 more
doaj +3 more sources
Harnessing Photo‐Energy Conversion in Nanomaterials for Precision Theranostics
Harnessing photo‐energy conversion in nanomaterials enables precision theranostics through light‐driven mechanisms such as photoluminescence, photothermal, photoelectric, photoacoustic, photo‐triggered surface‐enhanced Raman scattering (SERS), and photodynamic processes. This review explores six fundamental principles of photo‐energy conversion, recent
Jingyu Shi+4 more
wiley +1 more source
Patient Risk Assessment in the PACU: An Essential Element in Clinical Decision Making and Planning Care [PDF]
Pat Smedley
openalex +1 more source
Colonoscopic continuum robots lack sensing, endangering intestinal tissue. An ideal sensing array is hard to integrate. This work introduces a 3D crosslinked stretchable E‐armor with full‐coverage and multiplexing. It has bimodal sensing, forms a triboelectric synapse, uses CNN‐LSTM, and has a hydrogel and innovative triboelectric materials.
Yuyang Sun+8 more
wiley +1 more source
Survivorship Care Plans for Patients With Head and Neck Cancer [PDF]
Bruce H. Campbell+2 more
openalex +1 more source
Family involvement in geriatric hospitalization: a qualitative analysis of state regulations in Israel. [PDF]
Semyonov-Tal K, Davidov E.
europepmc +1 more source
Herein, a glutathione‐responsive system (named THN) is prepared for X‐ray‐triggered sustained ROS generation for efficient antitumor immunotherapy. The double‐promoting ROS generation of THN induced massive immunogenic cancer cell death and polarized M2 macrophages into the M1 phenotype for enhanced antitumor immunotherapy.
Qingyong Xu+10 more
wiley +1 more source